Perrigo | PRGO - Current Assets


Perrigo reported $2.4B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
AbbVie USD 37.48B 3.81B Sep/2026
Abbott USD 23.5B 1.02B Sep/2026
Bayer EUR 39.6B 5.96B Sep/2026
Bristol-Myers Squibb USD 29.77B 1.19B Sep/2026
Coherus Biosciences USD 133.79M 72.25M Jun/2026
Corcept Therapeutics USD 533.87M 94.2M Sep/2026
Dr.Reddys Laboratories INR 297.32B 2.01B Sep/2026
Eli Lilly USD 65.26B 591M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Merck USD 38.94B 2.26B Sep/2026
Nestle CHF 37.58B 5.61B Jun/2026
Pacira USD 10.3B 9.68B Sep/2026
Perrigo USD 2.4B 49.7M Sep/2026
Pfizer USD 45.01B 3.65B Sep/2026
Phibro Animal Health USD 945.17M 9.67M Sep/2026
Prestige Brands USD 492.13M 4.69M Sep/2026
Reckitt Benckiser GBP 4.6B 287M Dec/2024
Sanofi EUR 33.21B 1.68B Sep/2026
Supernus Pharmaceuticals USD 711.21M 12.28M Sep/2026
Teva Pharmaceutical Industries USD 14.6B 842M Sep/2026
Xeris Pharmaceuticals USD 289.26M 14.51M Sep/2026
Zoetis USD 6.29B 63M Sep/2026